HERON THERAPEUTICS, INC. /DE/ Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- HERON THERAPEUTICS, INC. /DE/ stock issued during period, value, stock options exercised for the quarter ending 2020-12-31 was $4.93M.
- HERON THERAPEUTICS, INC. /DE/ stock issued during period, value, stock options exercised for the quarter ending 2020-09-30 was $524.00K, a 86.98% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ stock issued during period, value, stock options exercised for the quarter ending 2020-06-30 was $805.00K, a 91.68% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ stock issued during period, value, stock options exercised for the quarter ending 2020-03-31 was $504.00K, a 92.29% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ stock issued during period, value, stock options exercised for fiscal 2020 was $6.76M, a 69.50% decline from fiscal 2019.
- HERON THERAPEUTICS, INC. /DE/ stock issued during period, value, stock options exercised for fiscal 2019 was $22.16M, a 21.11% increase from fiscal 2018.
- HERON THERAPEUTICS, INC. /DE/ stock issued during period, value, stock options exercised for fiscal 2018 was $18.30M, a 59.65% increase from fiscal 2017.
- HERON THERAPEUTICS, INC. /DE/ stock issued during period, value, stock options exercised for fiscal 2017 was $11.46M, a 71.50% increase from fiscal 2016.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2020-12-31 | $4.93M derived: 10-K 12 month − 3 quarters · filed 2021-02-24 | $6.76M 10-K · filed 2021-02-24 |
| 2020-09-30 | $524.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $805.00K 10-Q · filed 2020-11-05 | |
| 2020-03-31 | $504.00K 10-Q · filed 2020-11-05 | |
| 2019-12-31 | $22.16M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $4.02M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $9.68M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $6.54M 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $18.30M 10-K · filed 2021-02-24 | |
| 2018-09-30 | $5.13M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $6.44M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $4.20M 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $11.46M 10-K · filed 2020-03-02 | |
| 2016-12-31 | $6.68M 10-K · filed 2019-02-22 | |
| 2015-12-31 | $9.54M 10-K · filed 2018-02-27 | |
| 2014-12-31 | $3.10M 10-K · filed 2017-02-23 | |
| 2013-12-31 | $2.79M 10-K · filed 2016-02-19 | |
| 2010-12-31 | $47.00K 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |